|
Analyzing Primary Pulmonary Hypertension |
|
|
|
Primary Pulmonary Hypertension Defined
Primary
Pulmonary Hypertension is what doctors call a rare disorder of the blood
vessels and lungs. Also known as PPH, this disorder involves the
pulmonary artery, that large vein that extends from the heart to the
lungs. When the pressure of blood pumping through the pulmonary artery
increases to abnormal levels, it is considered possibly life-threatening.
Primary Pulmonary Hypertension Symptoms
PPH can include
the following symptoms:
A) chest pains
B) dizziness
C) fainting
D) fatigue
E) shortness
of breath when person is under little duress or exerting little effort
Primary
Pulmonary Hypertension Causes
The insidious nature of Primary
Pulmonary Hypertension is that it is without known causes: if causes are
identified, however, the disorder is considered Secondary Pulmonary
Hypertension. SPH is primarily caused, the experts determine, by such
illnesses as emphysema and bronchitis, and is also less often caused
by—say medical professionals at PH Association—CREST, scleroderma, or
SLE. PHA adds that other causes are congenital heart disease, chronic
pulmonary thromboembolism, diet drugs containing fen-fens, HIV, and
liver disease.
Primary Pulmonary Hypertension Treatment
While
a greater incidence of survival and healthy maintenance is reported in
individuals who are living with Primary Pulmonary Hypertension—up to 15
and 20 years—medical care is aggressive I its efforts to find beneficial
treatment. Doctors and other medical specialists continue to work with
such treatment solutions as anticoagulant therapy; digoxin and other
oral therapies, including the use of diuretics and oxygen
supplementation; and what Dr. Ronald J. Oudiz determines as [continued]
conventional oral vasodilator therapy.
Unique treatment plans are
considered, as individual circumstances for the patient with Primary
Pulmonary Hypertension vary from patient to patient. For instance, as
Dr. Oudiz reports, in the conventional vasodilator therapy session,
“high does of CCBs are used in patients with PPH…,” though “only
patients with an acute vasodilator response to an intravenous or inhaled
pulmonary vasodilator challenge…derive any long-term benefit from CCBs.”
This means, evidently, that only 20% of patients with Primary Pulmonary
Hypertension respond favorably to this particular kind of treatment….
As
the expert professionals at PH Association remind us, Primary Pulmonary
Hypertension is labeled with a “single name…” but “should not be
misconstrued…as being a single disorder.” In other words, this rare
disease (developing in approximately two out of every million people
each year) has many causes that are as yet undiscovered and unidentified
and has many fine minds working on a number of care and maintenance
solutions.
|
